 Endomyocardial Fibrosis
"Endomyocardial Fibrosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
| Descriptor ID |
D004719
|
| MeSH Number(s) |
C14.280.238.406
|
| Concept/Terms |
Endomyocardial Fibrosis- Endomyocardial Fibrosis
- Endomyocardial Fibroses
- Fibroses, Endomyocardial
- Fibrosis, Endomyocardial
|
Below are MeSH descriptors whose meaning is more general than "Endomyocardial Fibrosis".
Below are MeSH descriptors whose meaning is more specific than "Endomyocardial Fibrosis".
This graph shows the total number of publications written about "Endomyocardial Fibrosis" by people in this website by year, and whether "Endomyocardial Fibrosis" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1989 | 1 | 0 | 1 | | 2006 | 0 | 1 | 1 | | 2009 | 1 | 0 | 1 | | 2012 | 0 | 1 | 1 | | 2014 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Endomyocardial Fibrosis" by people in Profiles.
-
Nagalingam RS, Sundaresan NR, Noor M, Gupta MP, Solaro RJ, Gupta M. Deficiency of cardiomyocyte-specific microRNA-378 contributes to the development of cardiac fibrosis involving a transforming growth factor ß (TGFß1)-dependent paracrine mechanism. J Biol Chem. 2014 Sep 26; 289(39):27199-27215.
-
Zannad F, Gattis Stough W, Rossignol P, Bauersachs J, McMurray JJ, Swedberg K, Struthers AD, Voors AA, Ruilope LM, Bakris GL, O'Connor CM, Gheorghiade M, Mentz RJ, Cohen-Solal A, Maggioni AP, Beygui F, Filippatos GS, Massy ZA, Pathak A, Piña IL, Sabbah HN, Sica DA, Tavazzi L, Pitt B. Mineralocorticoid receptor antagonists for heart failure with reduced ejection fraction: integrating evidence into clinical practice. Eur Heart J. 2012 Nov; 33(22):2782-95.
-
Shapiro S, Pinney SP, Anyanwu AC, Garcia MJ. An atypical presentation of endomyocardial fibrosis diagnosed by cardiac MRI. Circ Heart Fail. 2009 Jan; 2(1):77-80.
-
Pillai JB, Gupta M, Rajamohan SB, Lang R, Raman J, Gupta MP. Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy. Am J Physiol Heart Circ Physiol. 2006 Oct; 291(4):H1545-53.
-
Pawlinski R, Fernandes A, Kehrle B, Pedersen B, Parry G, Erlich J, Pyo R, Gutstein D, Zhang J, Castellino F, Melis E, Carmeliet P, Baretton G, Luther T, Taubman M, Rosen E, Mackman N. Tissue factor deficiency causes cardiac fibrosis and left ventricular dysfunction. Proc Natl Acad Sci U S A. 2002 Nov 26; 99(24):15333-8.
-
Jalil JE, Janicki JS, Pick R, Abrahams C, Weber KT. Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circ Res. 1989 Aug; 65(2):258-64.
-
Herrmann G, Haverich A, Ziemer G, Luhmer I, Kallfelz HC, Borst HG. [Orthotopic heart transplantation in childhood and adolescence]. Monatsschr Kinderheilkd. 1988 Jun; 136(6):327-30.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|